# Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network

**Authors:** S. Pelliccia, A. Di Rocco, G. Palumbo, A. Zizzari, O. Annibali, E. Maiolo, A. Rago, G. Trapè, M. P. Bianchi, G. Pileggi, L. Filomeno, S. Hohaus, L. Rigacci, M. C. Cox, M. Martelli, G. La Verde, A. Di Napoli, A. Tafuri

PMC · DOI: 10.3389/fonc.2026.1812268 · 2026-03-11

## Full-text entities

- **Diseases:** Castleman disease (MESH:D005871)
- **Chemicals:** Siltuximab (MESH:C504234)

---
Source: https://tomesphere.com/paper/PMC13014615